The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 24, 2019

Filed:

Oct. 26, 2015
Applicant:

The Board of Trustees of the Leland Stanford Junior University, Palo Alto, CA (US);

Inventors:

Justin Du Bois, Menlo Park, CA (US);

John Mulcahy, Redwood City, CA (US);

Brian Andresen, Sharon, MA (US);

David C. Yeomans, Sunnyvale, CA (US);

Sandip Biswal, Stanford, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); C07D 487/16 (2006.01); C07D 487/14 (2006.01); A61K 8/49 (2006.01); A61K 49/00 (2006.01); A61Q 19/02 (2006.01); A61Q 19/08 (2006.01); A61K 51/04 (2006.01);
U.S. Cl.
CPC ...
C07D 487/16 (2013.01); A61K 8/4953 (2013.01); A61K 49/0002 (2013.01); A61K 49/0004 (2013.01); A61K 49/0032 (2013.01); A61K 49/0052 (2013.01); A61K 51/0459 (2013.01); A61Q 19/02 (2013.01); A61Q 19/08 (2013.01); C07D 487/14 (2013.01);
Abstract

Saxitoxin analogue compounds, compositions, pharmaceutical compositions, methods of synthesis of saxitoxin analogues, methods of imaging, methods of treatment, including methods of treating pain, are provided. Saxitoxin (STX), gonyautoxin (GTX), and zetekitoxin, and variant STX compounds bind to sodium channels and are effective to reduce or block flow of sodium ions through such channels. Such channel block affects nerve and muscle action, and may be effective to reduce or block pain sensations, relax muscles, reduce muscle spasm, and reduce wrinkles. STX analogue binding to sodium channels may also be useful to locate, image, or mark sodium channels, and so be useful in studying sodium channels and sodium channel disorders, and in the diagnosis and treatment of patients suffering from sodium channel disorders. In embodiments, the variant STX compounds include conjugates having increased serum half-life as compared to STX when administered to a subject. Also provided are methods for alleviating pain in a subject in need of treatment.


Find Patent Forward Citations

Loading…